XML 42 R19.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Collaborative Research and Development Agreements (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2015
Astra Zeneca |
Summary of Revenue Recognized under Various Agreements | The following table summarizes the revenues earned under our agreement with AstraZeneca, included as collaboration revenue in our consolidated statements of operations (in thousands):
| Three Months Ended |
| March 31, |
| 2015 |  |  | 2014 |
Initial payment | $ | 63 |  |  | $ | 180 |
Subsequent payment |  | 237 |  |  |  | 675 |
Performance of research activities |  | 171 |  |  |  | 887 |
Total | $ | 471 |  |  | $ | 1,742 |
National Institutes of Health |
Summary of Revenue Recognized under Various Agreements | The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands):
| Three Months Ended |
| March 31, |
| 2015 |  |  | 2014 |
NIAID contracts | $ | - |  |  | $ | 874 |
All other NIH contracts |  | 148 |  |  |  | 251 |
Total grant revenue | $ | 148 |  |  | $ | 1,125 |

X
- Definition Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 25 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=19771336&loc=SL6750900-111635 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=19771336&loc=d3e50766-111635 + Details
Name: | us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=dvax_AstraZenecaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=dvax_NationalInstitutesOfHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |